Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
eye diseases
Pharma
Bausch + Lomb CEO Brent Saunders hits the exit again
Analysts at Evercore and Leerink called the CEO transition a surprise as the eye care specialist appears to be growing on solid ground.
Angus Liu
Oct 12, 2026 10:53am
FDA approves Tenpoint's presbyopia combo treatment Yuvezzi
Jan 29, 2026 8:01am
Lenz ups Vizz visibility with Sarah Jessica Parker DTC campaign
Jan 14, 2026 11:37am
Apellis reports 4% sales drop for eye disease med Syfovre
Jan 12, 2026 1:06pm
Outlook stock plummets as FDA again snubs wet AMD drug
Aug 28, 2025 10:55am
Manufacturing issues cause FDA to delay decisions on Eylea HD
Aug 20, 2025 2:32pm
